A direct link to the ongoing phase III trial, that recently was activated in US centers, directs you to the NIH/NCI clinical trials web page - click here.
Review of the clinical development of Radium 223 - Alpharadin.
Chapter 10 in a recent textbook on targeted radionuclide tumour therapy by Springer Verlag, 2008.
Click here to open the chapter in PDF format.
In the latest issue of Clinical Cancer Research, a separate section is devoted to the proceedings from an expert meeting in Boston, October last year. Here invited papers on various aspects of the management of patients with bone metastases are published. This includes a review (by Bruland et al.) on external radiotherapy, bone-seeking radiopharamaceuticals, including recent progress using Alpharadin - a novel bone-seeker; currently in phase II clinical testing in patients with bone metastases from hormone refractory prostate cancer.
Click here to view the table of contents (PDF format)
High-Linear EnergyTransfer IrradiationTargeted to Skeletal Metastases by the A-Emitter 223Ra: Adjuvant or Alternative to Conventional Modalities? (PDF format)
Advances in Treating Metastatic Bone Cancer: Summary Statement for the First Cambridge Conference (PDF format)
|Two new papers in "Clinical Cancer Research"|
|Human osteosarcoma xenografts and their sensitivity to chemotherapy. Newly published article: (12.10.2004 16:36)|
|Onkologisk forum (19.11.2003 10:58)|